Nimotuzumab as Additional Therapy for GLIOMA in Pediatric and Adolescent: A Systematic Review
Published 2022 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Nimotuzumab as Additional Therapy for GLIOMA in Pediatric and Adolescent: A Systematic Review
Authors
Keywords
-
Journal
Cancer Control
Volume 29, Issue -, Pages 107327482110539
Publisher
SAGE Publications
Online
2022-02-23
DOI
10.1177/10732748211053927
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Diffuse Intrinsic Pontine Glioma (DIPG): breakthrough and clinical perspective
- (2020) Maria Grazia Perrone et al. CURRENT MEDICINAL CHEMISTRY
- Activation of Epidermal Growth Factor Receptor Sensitizes Glioblastoma Cells to Hypoxia-Induced Cell Death
- (2020) Anna-Luisa Luger et al. Cancers
- Nimotuzumab and radiotherapy for treatment of newly diagnosed diffuse intrinsic pontine glioma (DIPG): a phase III clinical study
- (2019) G. Fleischhack et al. JOURNAL OF NEURO-ONCOLOGY
- Reirradiation in patients with diffuse intrinsic pontine gliomas: The Canadian experience
- (2018) Alvaro Lassaletta et al. PEDIATRIC BLOOD & CANCER
- Akt and mTORC1 signaling as predictive biomarkers for the EGFR antibody nimotuzumab in glioblastoma
- (2018) Michael W. Ronellenfitsch et al. Acta Neuropathologica Communications
- Nimotuzumab-containing regimen for pediatric diffuse intrinsic pontine gliomas: a retrospective multicenter study and review of the literature
- (2018) Rejin Kebudi et al. CHILDS NERVOUS SYSTEM
- Survival benefit for patients with diffuse intrinsic pontine glioma (DIPG) undergoing re-irradiation at first progression: A matched-cohort analysis on behalf of the SIOP-E-HGG/DIPG working group
- (2017) Geert O. Janssens et al. EUROPEAN JOURNAL OF CANCER
- Phase III trial of nimotuzumab for the treatment of newly diagnosed diffuse intrinsic pontine gliomas in children and adolescents
- (2017) U. Bode et al. JOURNAL OF CLINICAL ONCOLOGY
- Diffuse Intrinsic Pontine Glioma: New Pathophysiological Insights and Emerging Therapeutic Targets
- (2016) Tessa Johung et al. Current Neuropharmacology
- Epidemiology of Brain Tumors
- (2016) Katharine A. McNeill NEUROLOGIC CLINICS
- ROBINS-I: a tool for assessing risk of bias in non-randomised studies of interventions
- (2016) Jonathan AC Sterne et al. BMJ-British Medical Journal
- ROBINS-I: a tool for assessing risk of bias in non-randomised studies of interventions
- (2016) Jonathan AC Sterne et al. BMJ-British Medical Journal
- Profile of nimotuzumab in the treatment of high-grade glioma
- (2015) Zhong-ping Chen et al. OncoTargets and Therapy
- Newcastle-Ottawa Scale: comparing reviewers’ to authors’ assessments
- (2014) Carson Ka-Lok Lo et al. BMC Medical Research Methodology
- Results of nimotuzumab and vinorelbine, radiation and re-irradiation for diffuse pontine glioma in childhood
- (2014) Maura Massimino et al. JOURNAL OF NEURO-ONCOLOGY
- Phase 2 study of safety and efficacy of nimotuzumab in pediatric patients with progressive diffuse intrinsic pontine glioma
- (2014) U. Bartels et al. NEURO-ONCOLOGY
- MR Imaging Assessment of Tumor Perfusion and 3D Segmented Volume at Baseline, during Treatment, and at Tumor Progression in Children with Newly Diagnosed Diffuse Intrinsic Pontine Glioma
- (2013) J. Sedlacik et al. AMERICAN JOURNAL OF NEURORADIOLOGY
- CBTRUS Statistical Report: Primary Brain and Central Nervous System Tumors Diagnosed in the United States in 2006-2010
- (2013) Q. T. Ostrom et al. NEURO-ONCOLOGY
- Pediatric diffuse intrinsic pontine glioma patients from a single center
- (2012) Rejin Kebudi et al. CHILDS NERVOUS SYSTEM
- Nimotuzumab treatment of malignant gliomas
- (2012) Udo Bode et al. EXPERT OPINION ON BIOLOGICAL THERAPY
- Diffuse intrinsic pontine glioma: poised for progress
- (2012) Katherine E. Warren Frontiers in Oncology
- Treatment of recurrent diffuse intrinsic pontine glioma: the MD Anderson Cancer Center experience
- (2011) Johannes E. Wolff et al. JOURNAL OF NEURO-ONCOLOGY
- Radiotherapy with concurrent and adjuvant temozolomide in children with newly diagnosed diffuse intrinsic pontine glioma
- (2011) Andrea Chassot et al. JOURNAL OF NEURO-ONCOLOGY
- Temozolomide in the treatment of children with newly diagnosed diffuse intrinsic pontine gliomas: a report from the Children's Oncology Group
- (2011) K. J. Cohen et al. NEURO-ONCOLOGY
- Nimotuzumab for pediatric diffuse intrinsic pontine gliomas
- (2010) Maura Massimino et al. EXPERT OPINION ON BIOLOGICAL THERAPY
- Radiosensitisation of U87MG brain tumours by anti-epidermal growth factor receptor monoclonal antibodies
- (2009) A Diaz Miqueli et al. BRITISH JOURNAL OF CANCER
- Outcome and prognostic features in pediatric gliomas
- (2009) Ibrahim Qaddoumi et al. CANCER
- Intensive chemotherapy improves survival in pediatric high-grade glioma after gross total resection: results of the HIT-GBM-C protocol
- (2009) Johannes E.A. Wolff et al. CANCER
- Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase III study: 5-year analysis of the EORTC-NCIC trial
- (2009) Roger Stupp et al. LANCET ONCOLOGY
- Young age may predict a better outcome for children with diffuse pontine glioma
- (2008) Alberto Broniscer et al. CANCER
- Chemotherapy for Malignant Brain Tumors of Childhood
- (2008) Nicholas G. Gottardo et al. JOURNAL OF CHILD NEUROLOGY
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started